You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

M9831

Showing 1 - 25 of 29
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumor Trial in United States (VX-984 120 mg + PLD 40 mg/m^2, VX-984 240 mg + PLD 40 mg/m^2, VX-984 480 mg + PLD

Completed
Has Results
  • Advanced Solid Tumor
  • VX-984 120 mg + PLD 40 mg/m^2
  • +3 more
  • Scottsdale, Arizona
  • +4 more
Jul 29, 2019

Describe to Better Understand, Mealtime of People With

Not yet recruiting
  • Parkinson Disease
  • Deglutition Disorders
    • Toulouse, Haute-Garonne, France
      Centre Expert Parkinson
    May 31, 2023

    Carotid Artery Plaque, Pd-1 Inhibitors Trial in Hangzhou (PD-1 inhibitor)

    Recruiting
    • Carotid Artery Plaque
    • Pd-1 Inhibitors
    • PD-1 inhibitor
    • Hangzhou, Zhejiang, China
      The Second Affiliated Hospital of Zhejiang University, School of
    Sep 17, 2022

    HER2-positive Breast Cancer, Breast Adenocarcinoma, Stage II Breast Cancer AJCC v6 and v7 Trial in San Francisco (Neratinib,

    Completed
    • HER2-positive Breast Cancer
    • +8 more
    • San Francisco, California
      University of California, San Francisco
    Jan 6, 2023

    HER2-positive Breast Cancer, Adjuvant Therapy Trial in Hangzhou (Paclitaxel, Trastuzumab, Docetaxel)

    Recruiting
    • HER2-positive Breast Cancer
    • Adjuvant Therapy
    • Hangzhou, Zhejiang, China
      2nd Affiliated Hospital, School of Medicine, Zhejiang University
    Dec 26, 2021

    SCID Trial in United States (Humanized anti-CD117 Monoclonal Antibody (JSP191))

    Recruiting
    • SCID
    • Humanized anti-CD117 Monoclonal Antibody (JSP191)
    • Los Angeles, California
    • +7 more
    Nov 16, 2021

    Plaque, Atherosclerotic, Immune Checkpoint Inhibitors, Programmed Cell Death Protein 1 Inhibitor Trial in Hangzhou (PD-1 immune

    Recruiting
    • Plaque, Atherosclerotic
    • +4 more
    • PD-1 immune checkpoint blockades
    • Hangzhou, Zhejiang, China
      The Second Affiliated Hospital of Zhejiang University, School of
    Nov 16, 2021

    Breakthrough Symptoms With Long-Acting Injectable Medications

    Not yet recruiting
    • Schizophrenia
    • Schizophrenia Relapse
    • Second Generation Long-Acting Injectable Antipsychotic Medications
    • (no location specified)
    Jul 22, 2022

    Mechanisms fo Clopidogrel Resistance in Older Adults (CEPAGE)

    Recruiting
    • Drug Resistance
    • additional blood sample
    • Paris, France
    • +3 more
    Nov 12, 2021

    Early Childhood Caries Trial in Winnipeg (silver diamine fluoride)

    Active, not recruiting
    • Early Childhood Caries
    • silver diamine fluoride
    • Winnipeg, Manitoba, Canada
      Children's Hospital Research Institute of Manitoba
    Oct 31, 2022

    Folate Trial in Toronto (Folic Acid supplementation, Adult Multivitamin)

    Active, not recruiting
    • Folate
    • Folic Acid supplementation
    • Adult Multivitamin
    • Toronto, Ontario, Canada
      St. Michael's Hospital
    Sep 1, 2021

    Breast Tumors Trial in Mönchengladbach (drug, diagnostic test, procedure)

    Active, not recruiting
    • Breast Neoplasms
    • Perjeta Injectable Product
    • +13 more
    • Mönchengladbach, Germany
      Evangelisches Krankenhaus Bethesda Mönchengladbach
    Oct 4, 2022

    Breast Cancer Trial in Canada, United States (herceptin, adriamycin, cyclophosphamide)

    Completed
    • Breast Cancer
    • herceptin
    • +3 more
    • Huntsville, Alabama
    • +148 more
    Apr 28, 2021

    Reference Interval of Vitamin D of Coastal Fishermen in Cox's

    Completed
    • Vitamin D Deficiency
    • Serum vitamin D assay
    • Cox's Bazar, Bangladesh
    • +1 more
    Aug 16, 2021

    Overweight and Obesity, Fat Burn Trial in Cambridge (Placebo control, GTE 1, GTE 2)

    Completed
    • Overweight and Obesity
    • Fat Burn
    • Placebo control
    • +2 more
    • Cambridge, United Kingdom
      Anglia Ruskin University
    Nov 9, 2020

    Dysmetabolic Iron Overload Syndrome, Genetic Hemochromatosis, Iron Absorption Trial in Clermont-Ferrand (polyphenols, Placebo)

    Completed
    • Dysmetabolic Iron Overload Syndrome
    • +3 more
    • polyphenols
    • Placebo
    • Clermont-Ferrand, France
      CHU Clermont-Ferrand
    Mar 29, 2019

    Pain Trial in Henderson (Thermacare heat wraps, TENS, sham heat)

    Unknown status
    • Pain
    • Thermacare heat wraps
    • +3 more
    • Henderson, Nevada
      Future Sciecne Technology
    Nov 13, 2018

    Arthritis, Psoriatic Trial in Worldwide (Guselkumab, Placebo)

    Completed
    Has Results
    • Arthritis, Psoriatic
    • Birmingham, Alabama
    • +94 more
    Jan 15, 2021

    Early Childhood Caries, Vitamin D Deficiency Trial in Riyadh (serum vitamin D , calcium , parathyroid hormone and albumin level)

    Completed
    • Early Childhood Caries, Vitamin D Deficiency
    • serum vitamin D , calcium , parathyroid hormone and albumin level
    • Riyadh, Saudi Arabia
      Reem Al-Nathsha
    May 10, 2018

    Asthma Trial in Cambridge (GSK2292767 50 µg, GSK2292767 500 µg, Placebo)

    Completed
    Has Results
    • Asthma
    • GSK2292767 50 μg
    • +2 more
    • Cambridge, United Kingdom
      GSK Investigational Site
    Jul 10, 2019

    Cardiotoxicity, Cardiomyopathies, Breast Cancer Trial in Stockholm (Subclinical cardiotoxicity surveillance and treatment)

    Unknown status
    • Cardiotoxicity
    • +2 more
    • Subclinical cardiotoxicity surveillance and treatment
    • Stockholm, Sweden
      Karolinska University Hospital
    Mar 6, 2018

    Healthy Volunteers Trial in Glendale (TAK-020, TAK-020 Placebo)

    Completed
    Has Results
    • Healthy Volunteers
    • Glendale, California
      (unnamed)
    Jun 20, 2018

    Obesity Trial (GBP-SPS, GBP-HPS, VSG-SPS)

    Completed
    • Obesity
    • GBP-SPS
    • +3 more
    • (no location specified)
    Jul 18, 2017

    Breast Cancer Trial in Singapore (Paclitaxel + Carboplatin + ASLAN001)

    Unknown status
    • Breast Cancer
    • Paclitaxel + Carboplatin + ASLAN001
    • Singapore, Singapore
      National University Hospital
    Feb 2, 2017

    Other Endocrine/Nutritional/Metabolic Disorder Trial in Austin, Logan (Nutritional Supplement Blend)

    Completed
    • Other Endocrine/Nutritional/Metabolic Disorder
    • Nutritional Supplement Blend
    • Austin, Texas
    • +1 more
    Sep 26, 2016